DK131586A - Transdermalt, antiallergisk, farmaceutisk praeparat - Google Patents

Transdermalt, antiallergisk, farmaceutisk praeparat Download PDF

Info

Publication number
DK131586A
DK131586A DK131586A DK131586A DK131586A DK 131586 A DK131586 A DK 131586A DK 131586 A DK131586 A DK 131586A DK 131586 A DK131586 A DK 131586A DK 131586 A DK131586 A DK 131586A
Authority
DK
Denmark
Prior art keywords
antiallergic
transdermal
pharmaceutical preparation
agents
azatadine
Prior art date
Application number
DK131586A
Other languages
English (en)
Other versions
DK131586D0 (da
DK164844C (da
DK164844B (da
Inventor
Joel August Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK131586D0 publication Critical patent/DK131586D0/da
Publication of DK131586A publication Critical patent/DK131586A/da
Publication of DK164844B publication Critical patent/DK164844B/da
Application granted granted Critical
Publication of DK164844C publication Critical patent/DK164844C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
DK131586A 1984-07-23 1986-03-21 Transdermalt effektivt topisk antiallergisk farmaceutisk middel indeholdende azatadin og anvendelse af azatadin til fremstilling af et saadant middel til topisk transdermal behandling af allergiske sygdomme DK164844C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63354184A 1984-07-23 1984-07-23
US63354184 1984-07-23
US8501246 1985-07-01
PCT/US1985/001246 WO1986000806A1 (en) 1984-07-23 1985-07-01 Transdermal delivery of azatadine

Publications (4)

Publication Number Publication Date
DK131586D0 DK131586D0 (da) 1986-03-21
DK131586A true DK131586A (da) 1986-03-21
DK164844B DK164844B (da) 1992-08-31
DK164844C DK164844C (da) 1993-01-11

Family

ID=24540048

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131586A DK164844C (da) 1984-07-23 1986-03-21 Transdermalt effektivt topisk antiallergisk farmaceutisk middel indeholdende azatadin og anvendelse af azatadin til fremstilling af et saadant middel til topisk transdermal behandling af allergiske sygdomme

Country Status (10)

Country Link
EP (1) EP0188538B1 (da)
JP (1) JPS61502751A (da)
AU (1) AU576884B2 (da)
CA (1) CA1263602A (da)
DE (1) DE3573532D1 (da)
DK (1) DK164844C (da)
IL (2) IL74853A (da)
NZ (1) NZ212800A (da)
WO (1) WO1986000806A1 (da)
ZA (1) ZA855485B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
US5422118A (en) * 1986-11-07 1995-06-06 Pure Pac, Inc. Transdermal administration of amines with minimal irritation and high transdermal flux rate
US4877618A (en) * 1988-03-18 1989-10-31 Reed Jr Fred D Transdermal drug delivery device
BR112019012573A2 (pt) 2016-12-20 2019-11-19 Lts Lohmann Therapie Systeme Ag sistema terapêutico transdérmico que contém asenapina e polissiloxano ou poli-isobutileno
MX2019007391A (es) * 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
KR20210022656A (ko) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 아세나핀을 함유하는 경피 치료 시스템

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435114A (en) * 1965-11-08 1969-03-25 Mead Johnson & Co Topical antihistaminic compositions containing methdilazine sulfoxide

Also Published As

Publication number Publication date
NZ212800A (en) 1989-01-06
AU4608285A (en) 1986-02-25
EP0188538B1 (en) 1989-10-11
WO1986000806A1 (en) 1986-02-13
DK131586D0 (da) 1986-03-21
DK164844C (da) 1993-01-11
DE3573532D1 (de) 1989-11-16
AU576884B2 (en) 1988-09-08
DK164844B (da) 1992-08-31
CA1263602A (en) 1989-12-05
EP0188538A1 (en) 1986-07-30
JPS61502751A (ja) 1986-11-27
IL75853A0 (en) 1985-11-29
IL74853A (en) 1988-08-31
ZA855485B (en) 1986-03-26

Similar Documents

Publication Publication Date Title
DE3787377D1 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
AU594805B2 (en) Means for the application of transdermally absorbable active susbstances
ES2055745T3 (es) Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.
KR880700670A (ko) 알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
IE791235L (en) Acyl-derivatives of carnitine.
GB8604528D0 (en) Therapeutic agents
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
DE3786714T2 (de) Therapeutisches Mittel für Hautgeschwüre.
DE3888994D1 (de) Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen.
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
NO873835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
ATE53767T1 (de) Mittel zur applikation von transdermal resorbierbaren wirkstoffen.
DE3750264T2 (de) Durchdringungserhöhende mittel für transdermale verabreichung systemischer mittel.
SE8703308D0 (sv) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
DE3577985D1 (de) Organotitan-verbindungen und oberflaechenbehandlungsmittel.
IT8720352A0 (it) Sostanza profilattica e terapeutica per disturbi epatici.
ES288065Y (es) Mesa camilla para tratamientos de belleza,masaje y similares
NO991047L (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
ATE63685T1 (de) Hautbehandlungsmittel.
DE3672196D1 (de) Formulierung auf basis von gelatine und glyzine zur behandlung der trockenheit der haut.
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed